143 related articles for article (PubMed ID: 15581417)
61. Engagement of the CrkL adaptor in interferon alpha signalling in BCR-ABL-expressing cells.
Grumbach IM; Mayer IA; Uddin S; Lekmine F; Majchrzak B; Yamauchi H; Fujita S; Druker B; Fish EN; Platanias LC
Br J Haematol; 2001 Feb; 112(2):327-36. PubMed ID: 11167825
[TBL] [Abstract][Full Text] [Related]
62. Interferon-alpha signalling in bovine adrenal chromaffin cells: involvement of signal-transducer and activator of transcription 1 and 2, extracellular signal-regulated protein kinases 1/2 and serine 31 phosphorylation of tyrosine hydroxylase.
Douglas SA; Bunn SJ
J Neuroendocrinol; 2009 Mar; 21(3):200-7. PubMed ID: 19207826
[TBL] [Abstract][Full Text] [Related]
63. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
64. Lack of p21waf1 and p27kip1 protein induction by interferon-alpha2a in human melanoma cell lines.
Bearzatto A; Orlandi L; De Marco C; Daidone MG; Zaffaroni N
Melanoma Res; 1999 Oct; 9(5):457-63. PubMed ID: 10596912
[TBL] [Abstract][Full Text] [Related]
65. Dissociation between IFN-alpha-induced anti-viral and growth signaling pathways.
Arora T; Floyd-Smith G; Espy MJ; Jelinek DF
J Immunol; 1999 Mar; 162(6):3289-97. PubMed ID: 10092781
[TBL] [Abstract][Full Text] [Related]
66. The p38 mitogen-activated protein kinase pathway and its role in interferon signaling.
Platanias LC
Pharmacol Ther; 2003 May; 98(2):129-42. PubMed ID: 12725866
[TBL] [Abstract][Full Text] [Related]
67. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
Yamamoto T; Nagano H; Sakon M; Wada H; Eguchi H; Kondo M; Damdinsuren B; Ota H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Yagita H; Monden M
Clin Cancer Res; 2004 Dec; 10(23):7884-95. PubMed ID: 15585621
[TBL] [Abstract][Full Text] [Related]
68. Potential of interferon-alpha in solid tumours: part 2.
Santhanam S; Decatris M; O'Byrne K
BioDrugs; 2002; 16(5):349-72. PubMed ID: 12408739
[TBL] [Abstract][Full Text] [Related]
69. Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivo.
Bruzzese F; Di Gennaro E; Avallone A; Pepe S; Arra C; Caraglia M; Tagliaferri P; Budillon A
Clin Cancer Res; 2006 Jan; 12(2):617-25. PubMed ID: 16428508
[TBL] [Abstract][Full Text] [Related]
70. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins.
David M; Petricoin E; Benjamin C; Pine R; Weber MJ; Larner AC
Science; 1995 Sep; 269(5231):1721-3. PubMed ID: 7569900
[TBL] [Abstract][Full Text] [Related]
71. Anchoring interferon alpha to apolipoprotein A-I reduces hematological toxicity while enhancing immunostimulatory properties.
Fioravanti J; González I; Medina-Echeverz J; Larrea E; Ardaiz N; González-Aseguinolaza G; Prieto J; Berraondo P
Hepatology; 2011 Jun; 53(6):1864-73. PubMed ID: 21425312
[TBL] [Abstract][Full Text] [Related]
72. 6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells.
Wonganan O; He YJ; Shen XF; Wongkrajang K; Suksamrarn A; Zhang GL; Wang F
Toxicol Appl Pharmacol; 2017 Dec; 336():31-39. PubMed ID: 29031523
[TBL] [Abstract][Full Text] [Related]
73. Cooperative TRAIL production mediates IFNα/Smac mimetic-induced cell death in TNFα-resistant solid cancer cells.
Roesler S; Eckhardt I; Wolf S; Fulda S
Oncotarget; 2016 Jan; 7(4):3709-25. PubMed ID: 26788912
[TBL] [Abstract][Full Text] [Related]
74. Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha.
Zhao LJ; He SF; Liu Y; Zhao P; Bian ZQ; Qi ZT
Cell Physiol Biochem; 2016; 40(1-2):77-90. PubMed ID: 27855377
[TBL] [Abstract][Full Text] [Related]
75. The intracellular domain of interferon-alpha receptor 2c (IFN-alphaR2c) chain is responsible for Stat activation.
Kotenko SV; Izotova LS; Mirochnitchenko OV; Lee C; Pestka S
Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5007-12. PubMed ID: 10220409
[TBL] [Abstract][Full Text] [Related]
76. Bozepinib, a novel small antitumor agent, induces PKR-mediated apoptosis and synergizes with IFNα triggering apoptosis, autophagy and senescence.
Marchal JA; Carrasco E; Ramirez A; Jiménez G; Olmedo C; Peran M; Agil A; Conejo-García A; Cruz-López O; Campos JM; García MÁ
Drug Des Devel Ther; 2013; 7():1301-13. PubMed ID: 24194639
[TBL] [Abstract][Full Text] [Related]
77. Interferon-alpha resistance in renal carcinoma cells is associated with defective induction of signal transducer and activator of transcription 1 which can be restored by a supernatant of phorbol 12-myristate 13-acetate stimulated peripheral blood mononuclear cells.
Brinckmann A; Axer S; Jakschies D; Dallmann I; Grosse J; Patzelt T; Bernier T; Emmendoerffer A; Atzpodien J
Br J Cancer; 2002 Feb; 86(3):449-55. PubMed ID: 11875714
[TBL] [Abstract][Full Text] [Related]
78. Interferon α in cancer immunoediting: From elimination to escape.
Vidal P
Scand J Immunol; 2020 May; 91(5):e12863. PubMed ID: 31909839
[TBL] [Abstract][Full Text] [Related]
79. Inflammatory signaling compromises cell responses to interferon alpha.
Huangfu WC; Qian J; Liu C; Liu J; Lokshin AE; Baker DP; Rui H; Fuchs SY
Oncogene; 2012 Jan; 31(2):161-72. PubMed ID: 21666722
[TBL] [Abstract][Full Text] [Related]
80. Context Is Key: Delineating the Unique Functions of IFNα and IFNβ in Disease.
Fox LE; Locke MC; Lenschow DJ
Front Immunol; 2020; 11():606874. PubMed ID: 33408718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
